Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-FR Version v12-EN
Language French English
Date Updated 2020-02-27 2020-02-27
Drug Identification Number 02241114 02241114
Brand name AVANDIA AVANDIA
Common or Proper name rosiglitazone (as rosiglitazone maleate) tablets rosiglitazone (as rosiglitazone maleate) tablets
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients ROSIGLITAZONE ROSIGLITAZONE
Strength(s) 8MG 8MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 60's 60's
ATC code A10BG A10BG
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-05-01 2019-05-01
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Company comments AVANDIA 2mg and 4mg will continue to be available. AVANDIA 2mg and 4mg will continue to be available.
Health Canada comments